PHA (polyhydroxyalkanoates) are biodegradable polyesters produced by bacterial fermentation. In orthopedic research, PHA-based materials are being investigated as an alternative to permanent metal hardware. This article covers how PHA-based implants are made and tested, what the evidence shows, and what procurement teams should watch as the technology matures.
The Problem With Metal Implants
Stainless steel, titanium, and cobalt-chrome plates and screws have carried orthopedic fixation for decades. They are strong and reliable, but they carry documented drawbacks:
- Stress shielding: metal is far stiffer than cortical bone, so the implant carries most of the load and surrounding bone remodels weaker over time, raising refracture risk near the plate.
- Second surgery: most metal hardware is removed after healing, adding cost, anesthesia exposure, and recovery time.
- Corrosion and imaging artifacts: metal ions can leach over years, and metal distorts CT and MRI, making healing assessment harder.
For selected indications — non-load-bearing fractures, bone voids, osteotomies, pediatric cases — biodegradable implants transfer load back to healing bone gradually and eliminate removal surgery.
How PHA Is Used in Bone Repair
The PHA family includes polyhydroxybutyrate (PHB) and its copolymer PHBV (polyhydroxybutyrate-co-hydroxyvalerate). In bone repair research, these materials take three main forms:
- Osteoconductive scaffolds: porous PHA scaffolds give bone cells a temporary structure to attach to and grow into, degrading as new tissue forms.
- Bone pins and screws: researchers have fabricated PHB/PHBV pins and interference screws; in vivo studies in animal models report bone formation around PHA implants with new tissue integrating at the implant surface.
- Composites: blending PHA with hydroxyapatite or tricalcium phosphate raises strength and mimics bone's mineral phase, addressing PHA's low stiffness.
PHA degrades through hydrolysis and enzymatic action into metabolites the body can clear, without the sharp acidic burst associated with some other polyesters.
Research Evidence
The evidence on PHA in bone repair is genuine but concentrated in preclinical work:
- Chen and Wu's 2005 review in Biomaterials, "The application of polyhydroxyalkanoates as tissue engineering materials," remains a standard reference on PHA scaffolds for bone tissue engineering, covering degradation, biocompatibility, and scaffold design (DOI: 10.1016/j.biomaterials.2005.04.036).
- A 2026 review in MDPI Polymers, "Polyhydroxyalkanoates in Bone Alloplastic Materials: State of the Art and Future Perspectives," surveys PHB/PHBV bone substitutes and their clinical potential (DOI: 10.3390/polym18121508).
- Hydroxyapatite-PHB composite studies, summarized in the MDPI Polymers review of hybrid PHA materials for tissue engineering (DOI: 10.3390/polym13111738), report improved compressive properties and osteoconductivity versus neat PHB.
An honest note on commercial status: the biodegradable devices actually used in clinics today are PLA-family implants. PLLA pins and screws such as BIOFIX and ActivaPin hold regulatory clearance and decades of clinical use. PHA-based bone implants remain largely preclinical — no PHA fixation device is broadly marketed yet — and that distinction matters for procurement timelines.
PHA vs PLA vs Magnesium for Bone Fixation
- PLA (PLLA): cleared pins and screws (BIOFIX, ActivaPin); degrades over roughly one to three years; strong but stiff, with possible crystalline remnants; radiolucent.
- PHA (PHB/PHBV): preclinical for bone fixation; generally slower degradation with less acidic byproducts; lower mechanical strength on its own, improved with ceramic reinforcement; radiolucent.
- Magnesium: a degradable metal under investigation; initial strength close to bone; fast degradation can produce hydrogen gas that collects in surrounding soft tissue, though newer alloys manage this better.
For imaging, PHA and PLA implants are radiolucent, so follow-up CT and MRI are not distorted by metal artifacts — an advantage over metal hardware.
What Orthopedic Procurement Should Watch
PHA bone implants are not a near-term purchasing decision for most hospitals, but three signals justify periodic review:
- Device pipeline: watch for PHA fixation devices entering clinical trials and regulatory review through FDA 510(k) or Health Canada pathways.
- Regulatory pathway: biodegradable devices typically follow Class II or III routes; clearance data on degradation and mechanical performance will define adoption.
- Reinforced formulations: hydroxyapatite- or tricalcium-phosphate-reinforced PHA is the formulation most likely to reach clinical strength requirements.
Meanwhile, clinics can act on the broader shift away from persistent plastics. CliniEco supplies PLA-based consumables today: biodegradable isolation gowns and heavy-absorbency PLA underpads replace single-use polypropylene items in orthopedic clinics, while nitrile exam gloves remain the standard for procedure use. For a related comparison, see PHA vs PLA as bioplastics for healthcare.
FAQ
Are PHA bone implants available?
Not commercially for bone fixation. PHA devices sit in preclinical and early clinical research; PLA-based pins and screws are the biodegradable implants currently cleared for use.
Do biodegradable implants need removal?
No — that is their purpose. They degrade as bone heals, so the second surgery metal hardware usually requires is eliminated.
How strong are PHA implants?
PHA alone is weaker than metal or PLA. Composites with hydroxyapatite or tricalcium phosphate improve strength, which is why most bone-repair research uses reinforced formulations.
Related Reading
Explore more guides in this category:
0 comments